LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
DexCom
DXCM
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Constellation Brands
STZ
(Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets | |||||||||
Cash, cash equivalents and short term investments | -68.79%7.91M | -90.87%3.1M | -73.90%7.41M | -73.90%7.41M | --24.85M | --25.34M | --33.99M | --28.4M | --28.4M |
-Cash and cash equivalents | -68.79%7.91M | -90.87%3.1M | -73.90%7.41M | -73.90%7.41M | --24.85M | --25.34M | --33.99M | --28.4M | --28.4M |
Receivables | -32.20%9.56M | -20.17%14.11M | -48.26%8.45M | -48.26%8.45M | --9.46M | --14.11M | --17.68M | --16.33M | --16.33M |
-Accounts receivable | -36.39%799K | 119.52%1.27M | 68.67%1.23M | 68.67%1.23M | --775K | --1.26M | --579K | --731K | --731K |
-Taxes receivable | 8.19%3.65M | -44.63%4.39M | -39.98%3.86M | -39.98%3.86M | --3.89M | --3.37M | --7.92M | --6.43M | --6.43M |
-Other receivables | -46.00%5.12M | -7.90%8.46M | -63.38%3.36M | -63.38%3.36M | --4.79M | --9.48M | --9.18M | --9.17M | --9.17M |
Inventory | -69.78%5.69M | -63.50%5.94M | -49.16%6.87M | -49.16%6.87M | --18.41M | --18.82M | --16.28M | --13.5M | --13.5M |
Prepaid assets | -55.16%1.52M | -53.77%2.27M | -80.35%771K | -80.35%771K | --1.99M | --3.38M | --4.9M | --3.92M | --3.92M |
Current deferred assets | ---- | ---- | --0 | --0 | --0 | --0 | --222K | --3.86M | --3.86M |
Total current assets | -59.97%24.68M | -65.20%25.42M | -64.40%23.5M | -64.40%23.5M | --54.7M | --61.65M | --73.07M | --66.01M | --66.01M |
Non current assets | |||||||||
Net PPE | 0.17%58.13M | -0.77%59.73M | 0.54%60.86M | 0.54%60.86M | --56.78M | --58.03M | --60.2M | --60.53M | --60.53M |
-Gross PPE | 8.42%69.39M | 6.08%69.5M | 6.27%68.99M | 6.27%68.99M | --63.3M | --64M | --65.51M | --64.92M | --64.92M |
-Accumulated depreciation | -88.60%-11.27M | -83.63%-9.76M | -85.27%-8.14M | -85.27%-8.14M | ---6.52M | ---5.97M | ---5.32M | ---4.39M | ---4.39M |
Goodwill and other intangible assets | -15.58%12.28M | -15.00%12.85M | -14.46%13.41M | -14.46%13.41M | --13.98M | --14.55M | --15.11M | --15.68M | --15.68M |
Other non current assets | -83.38%788K | -82.74%777K | 36.14%5.56M | 36.14%5.56M | --5.06M | --4.74M | --4.5M | --4.08M | --4.08M |
Total non current assets | -7.92%71.2M | -8.09%73.36M | -0.58%79.83M | -0.58%79.83M | --75.82M | --77.32M | --79.81M | --80.3M | --80.3M |
Total assets | -31.01%95.88M | -35.39%98.78M | -29.38%103.32M | -29.38%103.32M | --130.52M | --138.97M | --152.88M | --146.3M | --146.3M |
Liabilities | |||||||||
Current liabilities | |||||||||
Payables | -56.77%9.6M | -36.39%8.48M | -54.23%4.67M | -54.23%4.67M | --8M | --22.21M | --13.34M | --10.21M | --10.21M |
-accounts payable | -59.11%9.05M | -40.30%7.91M | -58.96%4.13M | -58.96%4.13M | --7.97M | --22.14M | --13.24M | --10.07M | --10.07M |
-Total tax payable | 682.86%548K | 502.08%578K | 274.48%543K | 274.48%543K | --26K | --70K | --96K | --145K | --145K |
Current accrued expenses | -32.74%5.99M | -33.65%6.16M | -28.10%9.19M | -28.10%9.19M | --11.49M | --8.91M | --9.29M | --12.78M | --12.78M |
Current debt and capital lease obligation | 809.90%33.91M | 1,233.62%33.99M | 21.39%35.95M | 21.39%35.95M | --30.68M | --3.73M | --2.55M | --29.62M | --29.62M |
-Current debt | 950.24%33.37M | 1,569.52%33.41M | 21.59%35.36M | 21.59%35.36M | --30.1M | --3.18M | --2M | --29.08M | --29.08M |
-Current capital lease obligation | -0.73%546K | 7.12%587K | 10.35%597K | 10.35%597K | --578K | --550K | --548K | --541K | --541K |
Current deferred liabilities | 0.00%738K | 0.00%738K | 0.00%738K | 0.00%738K | --738K | --738K | --738K | --738K | --738K |
Other current liabilities | ---- | ---- | -99.18%130K | -99.18%130K | --590K | --1.13M | --3.73M | --15.82M | --15.82M |
Current liabilities | 36.87%50.24M | 66.57%49.38M | -26.72%50.68M | -26.72%50.68M | --51.49M | --36.71M | --29.64M | --69.17M | --69.17M |
Non current liabilities | |||||||||
Long term debt and capital lease obligation | -10.48%27.96M | -23.94%26.87M | -28.22%26.31M | -28.22%26.31M | --27.81M | --31.24M | --35.33M | --36.65M | --36.65M |
-Long term debt | -9.16%27.27M | -23.33%26.04M | -27.86%25.34M | -27.86%25.34M | --26.72M | --30.02M | --33.96M | --35.13M | --35.13M |
-Long term capital lease obligation | -42.96%697K | -39.23%835K | -36.34%967K | -36.34%967K | --1.1M | --1.22M | --1.37M | --1.52M | --1.52M |
Non current deferred liabilities | -15.40%36.16M | 1.47%36.04M | -9.56%37.34M | -9.56%37.34M | --37.05M | --42.74M | --35.52M | --41.28M | --41.28M |
Derivative product liabilities | --0 | -94.62%141K | -72.10%674K | -72.10%674K | --1.24M | --3.06M | --2.62M | --2.42M | --2.42M |
Preferred securities outside stock equity | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --311.59M | --311.59M |
Other non current liabilities | ---- | ---- | -81.17%563K | -81.17%563K | --5.96M | --8.94M | --27.93M | --2.99M | --2.99M |
Total non current liabilities | -25.35%64.26M | -37.74%63.19M | -83.52%65.11M | -83.52%65.11M | --72.14M | --86.08M | --101.49M | --395.12M | --395.12M |
Total liabilities | -6.75%114.5M | -14.16%112.57M | -75.06%115.79M | -75.06%115.79M | --123.64M | --122.78M | --131.14M | --464.28M | --464.28M |
Shareholders'equity | |||||||||
Share capital | 0.00%7K | 0.00%7K | 600.00%7K | 600.00%7K | --7K | --7K | --7K | --1K | --1K |
-common stock | 0.00%7K | 0.00%7K | 600.00%7K | 600.00%7K | --7K | --7K | --7K | --1K | --1K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -18.20%-335.56M | -20.86%-327.88M | -21.52%-322.64M | -21.52%-322.64M | ---298.13M | ---283.9M | ---271.3M | ---265.51M | ---265.51M |
Paid-in capital | 4.96%303.69M | 6.97%300.86M | 560.84%297.47M | 560.84%297.47M | --295.33M | --289.33M | --281.25M | ---64.55M | ---64.55M |
Gains losses not affecting retained earnings | 198.55%339K | 301.22%329K | -52.51%104K | -52.51%104K | ---810K | ---344K | --82K | --219K | --219K |
Total stockholders'equity | -718.36%-31.53M | -365.91%-26.69M | 92.40%-25.06M | 92.40%-25.06M | ---3.6M | --5.1M | --10.04M | ---329.84M | ---329.84M |
Noncontrolling interests | 16.40%12.91M | 10.18%12.9M | 6.20%12.59M | 6.20%12.59M | --10.47M | --11.09M | --11.7M | --11.86M | --11.86M |
Total equity | -215.07%-18.63M | -163.44%-13.79M | 96.08%-12.47M | 96.08%-12.47M | --6.88M | --16.19M | --21.74M | ---317.98M | ---317.98M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |